Davis's Drug Guide
riTUXimab
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Genetic Implications:
Pronunciation:
ri-tux-i-mab
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Riabni
- Rituxan
- Riximyo
- Ruxience
- Truxima
Ther. Class.
Pharm. Class.
monoclonal antibodies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "RiTUXimab." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Anesthesia Central, anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/51672/all/riTUXimab.
Vallerand AHA, Sanoski CAC, . RiTUXimab. Davis's Drug Guide. F.A. Davis Company; 2025. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/51672/all/riTUXimab. Accessed May 10, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). RiTUXimab. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/51672/all/riTUXimab
Vallerand AHA, Sanoski CAC, . RiTUXimab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 May 10]. Available from: https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/51672/all/riTUXimab.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - riTUXimab
ID - 51672
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/51672/all/riTUXimab
PB - F.A. Davis Company
ET - 19
DB - Anesthesia Central
DP - Unbound Medicine
ER -
